- $207.37m
- $208.33m
- $66.58m
Brief: Exagen Inc Expands In-Network Access With Evolutions Healthcare Systems
U.S. RESEARCH ROUNDUP- Agrify, Okta, Schnitzer Steel Industries
U.S. RESEARCH ROUNDUP- Adobe, Aligos Therapeutics
U.S. RESEARCH ROUNDUP- Adobe, Aligos Therapeutics
Exagen Inc reports results for the quarter ended in December - Earnings Summary
Exagen Inc expected to post a loss of 50cents a share - Earnings Preview
Brief: Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board
Exagen Inc reports results for the quarter ended in September - Earnings Summary
Brief: Exagen Posts Q3 Loss Per Share Of $0.42
Exagen Inc expected to post a loss of 46 cents a share - Earnings Preview
Brief: Exagen Inc Announces $27.2 Million Debt Refinancing
Exagen Inc reports results for the quarter ended in June - Earnings Summary
Promotion Agreement, Dated December 10, 2018
Exagen Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: Exagen Says Board Approved Increase In Size From Eight Members To Nine Members
Brief: Exagen Appoints Ana Hooker To Board
Exagen Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: Exagen Elects Frank Stokes To Board Of Directors
Exagen Inc reports results for the quarter ended in March - Earnings Summary